• Skip to main content
  • Es
  • En
Linkedin
  • By Phases
    • Preclinical and R&D
      • Biomarkers Analysis
      • Immunogenicity Assay
      • Metabolomics
      • Nucleic Acid Bioanalysis & Gene Therapy
      • Pharmacokinetic Analysis (PK/PD)
      • Regulated Impurities
      • Analytical Method Development, Validation & Transfer
      • Oligonucleotides
      • Peptide and Amino Acid Analysis
      • Protein and Biologics Characterization
      • Protein Analysis
    • CMC and QC
      • Biosimilar Services
      • Microbiology Control
      • QC Testing
      • Vaccine Analysis
      • Metabolomics
      • Nucleic Acid and Gene Therapy
      • Oligonucleotides
      • Peptide and Amino Acid Analysis
      • Protein Analysis
      • Regulated Impurities
      • Analytical Method Development, Validation & Transfer
  • By Molecules
    • Small Molecule
    • TIDES
    • Biologics
    • Advanced Therapies
  • About us
    • AMSbiopharma
    • Innovation
    • Quality
    • Careers
  • News
  • Contact
  • By Phases
    • Preclinical and R&D
      • Biomarkers Analysis
      • Immunogenicity Assay
      • Metabolomics
      • Nucleic Acid Bioanalysis & Gene Therapy
      • Pharmacokinetic Analysis (PK/PD)
      • Regulated Impurities
      • Analytical Method Development, Validation & Transfer
      • Oligonucleotides
      • Peptide and Amino Acid Analysis
      • Protein and Biologics Characterization
      • Protein Analysis
    • CMC and QC
      • Biosimilar Services
      • Microbiology Control
      • QC Testing
      • Vaccine Analysis
      • Metabolomics
      • Nucleic Acid and Gene Therapy
      • Oligonucleotides
      • Peptide and Amino Acid Analysis
      • Protein Analysis
      • Regulated Impurities
      • Analytical Method Development, Validation & Transfer
  • By Molecules
    • Small Molecule
    • TIDES
    • Biologics
    • Advanced Therapies
  • About us
    • AMSbiopharma
    • Innovation
    • Quality
    • Careers
  • News
  • Contact

AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025)

Posted on: 18/02/2025 Last updated on: 12/08/2025 Written by: amsbiowp
We are pleased to announce that AMSbiopharma will be an official sponsor of the XIX Iberian Peptides Meeting (EPI 2025), which will take place from February 26 to 28, 2025. This biennial event is a key meeting point for Portuguese…
Continue reading “AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025)”…

Contact us

Let´s talk about your project 

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Subscribe to our newsletter

Stay informed with the latest news, updates, exclusive content, insightful articles, and important event announcements.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • R&D and Preclinical
    • Bioanalysis and biomarkers​
    • Metabolomics
  • Quality Control
    • Regulated Impurities / GMP
    • Analytical Method Development / GMP
    • Peptide and Amino Acid Analysis / Non-GLP
    • Oligonucleotides / Non-GLP
    • ICP-MS Analysis
    • Quality Control (QC) Testing / GMP
    • Microbiology
    • Medical cannabis
  • About us
    • AMSbiopharma
    • Innovation
    • Careers
  • News
  • Contact us
  • R&D and Preclinical
    • Bioanalysis and biomarkers​
    • Metabolomics
  • Quality Control
    • Regulated Impurities / GMP
    • Analytical Method Development / GMP
    • Peptide and Amino Acid Analysis / Non-GLP
    • Oligonucleotides / Non-GLP
    • ICP-MS Analysis
    • Quality Control (QC) Testing / GMP
    • Microbiology
    • Medical cannabis
  • About us
    • AMSbiopharma
    • Innovation
    • Careers
  • News
  • Contact us
  • Cookies Policy
  • Privacy Policy
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Legal Notice
Linkedin

AMSbiopharma a company of AMSlab – All rights reserved © 2024 | Made with love by ingenyus*